Striatal dopamine D2/D3 receptor regulation of human reward processing and behaviour

被引:0
|
作者
Osugo, Martin [1 ,2 ,3 ]
Wall, Matthew B. [4 ,5 ]
Selvaggi, Pierluigi [6 ,7 ]
Zahid, Uzma [1 ,8 ]
Finelli, Valeria [1 ]
Chapman, George E. [1 ,2 ,9 ,10 ]
Whitehurst, Thomas [2 ,11 ]
Onwordi, Ellis Chika [1 ,2 ,11 ,12 ]
Statton, Ben [2 ,5 ]
Mccutcheon, Robert A. [1 ,2 ,13 ,14 ]
Murray, Robin M. [1 ]
Marques, Tiago Reis [1 ,2 ]
Mehta, Mitul A. [6 ]
Howes, Oliver D. [1 ,2 ,3 ]
机构
[1] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England
[2] Imperial Coll London, MRC Lab Med Sci, London, England
[3] South London & Maudsley NHS Fdn Trust, London, England
[4] Perceptive, London, England
[5] Imperial Coll London, Fac Med, London, England
[6] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Neuroimaging, London, England
[7] Univ Bari Aldo Moro, Dept Translat Biomed & Neurosci, Bari, Italy
[8] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England
[9] UCL, Fac Brain Sci, Div Psychiat, London, England
[10] North London NHS Fdn Trust, London, England
[11] East London NHS Fdn Trust, London, England
[12] Queen Mary Univ London, Wolfson Inst Populat Hlth, Ctr Psychiat & Mental Hlth, London, England
[13] Univ Oxford, Dept Psychiat, Oxford, England
[14] Oxford Hlth NHS Fdn Trust, Oxford, England
基金
英国医学研究理事会; 英国惠康基金; 欧盟地平线“2020”;
关键词
NEGATIVE SYMPTOM SCALE; SCHIZOPHRENIA; ARIPIPRAZOLE; ANTICIPATION; ACTIVATION; PREDICTION; BIFEPRUNOX; MOTIVATION; GLUTAMATE; OUTCOMES;
D O I
10.1038/s41467-025-56663-7
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Signalling at dopamine D2/D3 receptors is thought to underlie motivated behaviour, pleasure experiences and emotional expression based on animal studies, but it is unclear if this is the case in humans or how this relates to neural processing of reward stimuli. Using a randomised, double-blind, placebo-controlled, crossover neuroimaging study, we show in healthy humans that sustained dopamine D2/D3 receptor antagonism for 7 days results in negative symptoms (impairments in motivated behaviour, hedonic experience, verbal and emotional expression) and that this is related to blunted striatal response to reward stimuli. In contrast, 7 days of partial D2/D3 agonism does not disrupt reward signalling, motivated behaviour or hedonic experience. Both D2/D3 antagonism and partial agonism induce motor impairments, which are not related to striatal reward response. These findings identify a central role for D2/D3 signalling and reward processing in the mechanism underlying motivated behaviour and emotional responses in humans, with implications for understanding neuropsychiatric disorders such as schizophrenia and Parkinson's disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Dopamine D2 receptor-dependent modulation of striatal NO synthase activity
    Sammut, Stephen
    Bray, Kristina E.
    West, Anthony R.
    PSYCHOPHARMACOLOGY, 2007, 191 (03) : 793 - 803
  • [32] Dopamine D2 receptor-dependent modulation of striatal NO synthase activity
    Stephen Sammut
    Kristina E. Bray
    Anthony R. West
    Psychopharmacology, 2007, 191 : 793 - 803
  • [33] Prevention of Neurite Spine Loss Induced by Dopamine D2 Receptor Overactivation in Striatal Neurons
    Zheng, Peng
    Su, Qian Peter
    Jin, Dayong
    Yu, Yinghua
    Huang, Xu-Feng
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [34] In Vivo Dopamine D3 and D2 Receptor Occupancy Profile of Cariprazine Versus Aripiprazole: A PET Study
    Girgis, Ragy
    Abi-Dargham, Anissa
    Slifstein, Mark
    Chen, Laishun
    Periclou, Antonia
    Adham, Nika
    Earley, Willie
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S595 - S596
  • [35] Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients
    Bressan, RA
    Erlandsson, K
    Spencer, EP
    Ell, PJ
    Pilowsky, LS
    PSYCHOPHARMACOLOGY, 2004, 175 (03) : 367 - 373
  • [36] Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients
    Rodrigo A. Bressan
    Kjell Erlandsson
    Edgar P. Spencer
    Peter J. Ell
    Lyn S. Pilowsky
    Psychopharmacology, 2004, 175 : 367 - 373
  • [37] Main interactions of dopamine and risperidone with the dopamine D2 receptor
    Martinez, Ana
    Garcia-Gutierrez, Ponciano
    Zubillaga, Rafael A.
    Garza, Jorge
    Vargas, Rubicelia
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2021, 23 (26) : 14224 - 14230
  • [38] Seasonal variation in D2/3 dopamine receptor availability in the human brain
    Sun, Lihua
    Malen, Tuulia
    Tuisku, Jouni
    Kaasinen, Valtteri
    Hietala, Jarmo A.
    Rinne, Juha
    Nuutila, Pirjo
    Nummenmaa, Lauri
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (11) : 3284 - 3291
  • [39] The mRNA Expression Status of Dopamine Receptor D2, Dopamine Receptor D3 and DARPP-32 in T Lymphocytes of Patients with Early Psychosis
    Cui, Yin
    Prabhu, Vishwanath
    Thong Ba Nguyen
    Yadav, Binod Kumar
    Chung, Young-Chul
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (11) : 26677 - 26686
  • [40] Striatal and Extrastriatal Dopamine D2/D3 Receptors in Schizophrenia Evaluated With [18F]fallypride Positron Emission Tomography
    Kegeles, Lawrence S.
    Slifstein, Mark
    Xu, Xiaoyan
    Urban, Nina
    Thompson, Judy L.
    Moadel, Tiffany
    Harkavy-Friedman, Jill M.
    Gil, Roberto
    Laruelle, Marc
    Abi-Dargham, Anissa
    BIOLOGICAL PSYCHIATRY, 2010, 68 (07) : 634 - 641